Database | Recombinant Antibodies And Mimetics Database

What can we help you find?

You are searching for:

Category A

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category B

Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation

Category C

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category D

Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category E

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category F

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with animal-derived biomaterials used in production or final formulation

Category G

Original source/host: Unknown
Discovery method: Unknown
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Uncategorised Antibodies

Uncategorised Antibodies have Antibody/Binder Origins set in such a way as to prevent them from being assigned to a valid Antibody Category.

Click here to view all Antibody Category descriptions and to search directly by Antibody Category

Category A
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category B
- Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
- Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
- Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
Search
Category C
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category D
- Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category E
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category F
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
Search
Category G
- Original source/host: Unknown
- Discovery method: Unknown
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search

181-190 of 8074 results

Catalogue Number:

94871

Category:

Adora2a/Adenosine Receptor A2a (E5I8X) XP® Rabbit mAb

References available

Target:	ADORA2A mouse
Target Alias Name:	ADORA2A
Species Reactivity:	Mouse, Rat
Applications:	Immunofluorescence, Immunohistochemistry
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Animal-Derived Biomaterials Used:	BSA
Sequence Available	Yes
Original Discovery Method	Immunization
Antibody/Binder Origins:	Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

bsm-90071R

Category:

ADP ribosylation factor 1 Recombinant Antbody Kit (KD-Validated)

Target:	ADP Ribosylation Factor 1
Target Alias Names:	ARF1, ADP Ribosylation Factor 1, ADP-Ribosylation Factor 1, EC 3.6.5.2, PVNH8
Species Reactivity:	Human, Mouse, Rat
Applications:	Flow Cytometry, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Native display libraries from animal B cells
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

bsm-90105R

Category:

ADP ribosylation factor 5 Recombinant Antbody Kit (KD-Validated)

Target:	ADP Ribosylation Factor 5
Target Alias Names:	ARF5, ADP Ribosylation Factor 5, ADP-Ribosylation Factor 5
Species Reactivity:	Human, Mouse, Rat
Applications:	Flow Cytometry, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Native display libraries from animal B cells
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

bsm-90075R

Category:

ADP ribosylation factor 6 Recombinant Antbody Kit (KD-Validated)

Target:	ADP Ribosylation Factor 6
Target Alias Names:	ARF6, ADP Ribosylation Factor 6, ADP-Ribosylation Factor 6, EC 3.6.5.2
Species Reactivity:	Human, Mouse, Rat
Applications:	Flow Cytometry, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Native display libraries from animal B cells
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

bsm-62553R

Category:

ADRA1A Recombinant Antibody

Target:	ADRA1A
Target Alias Names:	ADRA1A, Adra1c, ADRA1L1, ALPHA1AAR.
Species Reactivity:	Human, Mouse, Rat
Applications:	Flow Cytometry, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Native display libraries from animal B cells
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

bsm-62613R

Category:

Adrenodoxin Recombinant Antibody

Target:	Adrenodoxin
Target Alias Names:	Adrenodoxin, ADX, FDX, fdx1, Ferredoxin 1, Hepatoredoxin, LOH11CR1D.
Species Reactivity:	Human, Mouse, Rat
Applications:	Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Native display libraries from animal B cells
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

12019

Category:

ADRM1 (D9Z1U) Rabbit mAb

References available

Target:	ADRM1
Target Alias Name:	ADRM1
Species Reactivity:	Human, Mouse, Rat, Other
Applications:	Immunoprecipitation, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Animal-Derived Biomaterials Used:	BSA
Sequence Available	Yes
Original Discovery Method	Immunization
Antibody/Binder Origins:	Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

bsm-90038R

Category:

AdSS 2 Recombinant Antbody Kit (KD-Validated)

Target:	Adenylosuccinate Synthase 2
Target Alias Names:	ADSS2, Adenylosuccinate Synthase 2, ADSS, Adenylosuccinate Synthetase Acidic Isozyme, Adenylosuccinate Synthetase Liver Isozyme, Adenylosuccinate Synthetase Isozyme 2, L-Type Adenylosuccinate Synthetase, IMP--Aspartate Ligase 2, EC 6.3.4.4, AMPSase 2, Adenylosuccinate Synthetase (Ade(-)H-Complementing), Epididymis Secretory Sperm Binding Protein, Adenylosuccinate Synthase, ADSS 2, AdSS 2, ADEH
Species Reactivity:	Human, Mouse, Rat
Applications:	Flow Cytometry, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Native display libraries from animal B cells
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

bsm-62680R

Category:

AdSS2 Recombinant Antibody

Target:	AdSS2
Target Alias Names:	ADEH, ADSS, AMPSase 2.
Species Reactivity:	Human, Mouse, Rat
Applications:	Flow Cytometry, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Native display libraries from animal B cells
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

23276

Category:

AE1/SLC4A1 (D3X1R) Rabbit mAb

Target:	AE1
Target Alias Name:	SLC4A1
Species Reactivity:	Human, Mouse, Rat
Application:	Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Animal-Derived Biomaterials Used:	BSA
Sequence Available	Yes
Original Discovery Method	Immunization
Antibody/Binder Origins:	Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Viewing 181-190 of 8074 results

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.